Piramal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DK501011
  • NSEID: PPLPHARMA
  • BSEID: 543635
INR
213.61
4.06 (1.94%)
BSENSE

Aug 10, 03:30 PM

BSE+NSE Vol: 94.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
1,327.16
1,324.35
1,322.95
1,193.32
1,185.91
994.60
Share Warrants & Outstandings
Total Reserve
6,762.67
6,738.96
6,560.95
5,580.18
5,510.69
4,610.30
Shareholder's Funds
8,162.62
8,125.47
7,911.37
6,773.50
6,696.60
5,605.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
4,299.97
3,214.07
2,483.75
3,383.54
2,622.14
2,339.16
Secured Loans
4,299.97
3,214.07
2,483.75
3,383.54
2,622.14
2,339.16
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-156.55
-144.78
-157.32
-129.99
-105.26
-21.63
Other Long Term Liabilities
291.68
274.77
285.89
282.48
240.36
236.07
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
94.31
48.66
32.32
20.68
12.59
6.78
Total Non-Current Liabilities
4,529.41
3,392.72
2,644.64
3,556.71
2,769.83
2,560.38
Current Liabilities
Trade Payables
2,479.11
1,533.77
1,538.37
1,192.71
1,026.35
917.94
Other Current Liabilities
1,041.45
683.45
712.25
489.90
572.04
969.53
Short Term Borrowings
1,195.51
1,506.20
2,075.11
2,121.23
1,401.14
571.03
Short Term Provisions
42.21
42.85
43.57
39.21
33.81
31.78
Total Current Liabilities
4,758.28
3,766.27
4,369.30
3,843.05
3,033.34
2,490.28
Total Liabilities
17,450.31
15,284.46
14,925.31
14,173.26
12,499.77
10,655.66
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
14,437.27
12,718.43
11,721.86
10,616.64
9,331.97
8,022.50
Less: Accumulated Depreciation
6,145.28
4,943.39
4,109.56
3,373.52
2,631.31
2,047.19
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
8,291.99
7,775.04
7,612.30
7,243.12
6,700.66
5,975.31
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
799.17
489.12
565.70
852.93
673.15
399.53
Intangible assets under development
300.62
487.78
550.10
565.65
499.19
227.12
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
305.01
271.09
240.26
211.87
216.77
122.67
Long Term Loans & Advances
167.03
106.05
114.85
238.69
164.22
152.11
Other Non Current Assets
2.86
0.00
0.00
0.04
0.04
0.04
Total Non-Current Assets
10,258.65
9,487.47
9,460.84
9,337.78
8,432.55
7,006.96
Current Assets Loans & Advances
Current Investments
131.78
19.56
144.69
427.11
50.40
0.00
Inventories
3,064.44
2,312.70
2,175.88
1,681.37
1,388.80
1,232.00
Sundry Debtors
2,157.67
2,349.52
2,134.43
1,799.34
1,785.28
1,574.94
Cash and Bank
1,223.64
501.46
482.56
307.56
328.99
405.62
Other Current Assets
194.48
164.12
81.52
118.30
114.26
157.45
Short Term Loans and Advances
419.65
449.63
445.39
501.80
399.49
278.69
Total Current Assets
7,191.66
5,796.99
5,464.47
4,835.48
4,067.22
3,648.70
Net Current Assets (Including Current Investments)
2,433.38
2,030.72
1,095.17
992.43
1,033.88
1,158.42
Total Current Assets Excluding Current Investments
7,059.88
5,777.43
5,319.78
4,408.37
4,016.82
3,648.70
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
17,450.31
15,284.46
14,925.31
14,173.26
12,499.77
10,655.66
Contingent Liabilities
95.72
99.76
61.43
57.32
44.94
29.98
Total Debt
5,495.48
4,720.27
4,558.86
5,504.77
4,023.28
2,910.19
Book Value per share (adjusted)
61.5
61.35
59.8
55.4329355235658
55.1502544119227
55.0330589005108
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 16.42% vs 3.54% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 6.15% vs -3.89% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 10.01% vs 1.05% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 12.51% vs 12.83% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 24.06% vs 6.09% in Mar 2025

Compare Balance Sheet Results of Piramal Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
1,327.16
20.84
1,306.32
6,268.33%
Share Warrants & Outstandings
Total Reserve
6,762.67
2,102.43
4,660.24
221.66%
Shareholder's Funds
8,162.62
2,128.35
6,034.27
283.52%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
4,299.97
0.00
4,299.97
0.00%
Secured Loans
4,299.97
0.00
4,299.97
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-156.55
96.84
-253.39
-261.66%
Other Long Term Liabilities
291.68
164.69
126.99
77.11%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
94.31
23.41
70.90
302.86%
Total Non-Current Liabilities
4,529.41
284.93
4,244.48
1,489.66%
Current Liabilities
Trade Payables
2,479.11
322.51
2,156.60
668.69%
Other Current Liabilities
1,041.45
270.59
770.86
284.88%
Short Term Borrowings
1,195.51
128.64
1,066.87
829.35%
Short Term Provisions
42.21
10.76
31.45
292.29%
Total Current Liabilities
4,758.28
732.49
4,025.79
549.60%
Total Liabilities
17,450.31
3,145.78
14,304.53
454.72%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
14,437.27
1,610.23
12,827.04
796.60%
Less: Accumulated Depreciation
6,145.28
414.36
5,730.92
1,383.08%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
8,291.99
1,195.87
7,096.12
593.39%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
799.17
124.46
674.71
542.11%
Intangible assets under development
300.62
0.00
300.62
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
305.01
1.94
303.07
15,622.16%
Long Term Loans & Advances
167.03
19.57
147.46
753.50%
Other Non Current Assets
2.86
7.08
-4.22
-59.60%
Total Non-Current Assets
10,258.65
1,641.27
8,617.38
525.04%
Current Assets Loans & Advances
Current Investments
131.78
0.00
131.78
0.00%
Inventories
3,064.44
118.86
2,945.58
2,478.19%
Sundry Debtors
2,157.67
354.78
1,802.89
508.17%
Cash and Bank
1,223.64
463.88
759.76
163.78%
Other Current Assets
194.48
458.44
-263.96
-57.58%
Short Term Loans and Advances
419.65
108.54
311.11
286.63%
Total Current Assets
7,191.66
1,504.51
5,687.15
378.01%
Net Current Assets (Including Current Investments)
2,433.38
772.02
1,661.36
215.20%
Total Current Assets Excluding Current Investments
7,059.88
1,504.51
5,555.37
369.25%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
17,450.31
3,145.78
14,304.53
454.72%
Contingent Liabilities
95.72
58.11
37.61
64.72%
Total Debt
5,495.48
128.64
5,366.84
4,171.98%
Book Value per share (adjusted)
61.50
102.12
-40.62
-39.78%
Annual - Borrowings
Borrowings 5,495.48 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.42% vs 3.54% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 291.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.15% vs -3.89% in Mar 2025

Annual - Fixed Assets
Fixed Assets 9,091.16 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 10.01% vs 1.05% in Mar 2025

Annual - Investments
Investments 305.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.51% vs 12.83% in Mar 2025

Annual - Current Assets
Current Assets 7,191.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 24.06% vs 6.09% in Mar 2025